Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-30

Clinical Trial Update: Iloprost in Acute Respiratory Distress Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of iloprost for acute respiratory distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloprost (iloprost)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Respiratory Distress Syndrome, Adult | Phase 3 | Status: COMPLETED